KIT and asthma: Cahill et al. has conducted a Phase 2 trial to evaluate the effects of c-Kit inhibition with imatinib in severe asthma patients (45), and The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) also launched a Phase 2 trial, which includes imatinib for treating severe asthma (46).